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Workshop on Human Health Impacts of
Halogenated Biphenyls and Related
Compounds
by Michael A. Kamrin* and Lawrence J. Fischer*
A workshop on the Human Health Impacts ofHalogenated Biphenyls and Related Compounds was
held to assess the state of cui cent research on these chenticals and to make recommendations for
future studies. Participants discussed results from laboratory animal experiments on PCBs, PBBs,
dioxins, and dibenzofurans which demonstrate a common mode of toxicological action while also
revealinglargevariations intoxicologicalpotency both within andbetweenthese chemical families.
These variations demonstrate the importance ofcongener-specific analyses in future studies of ef-
fects of exposure to these compounds. Results from epidemiological studies of environmentally ex-
posed adult andpediatric populations fromthe U.S., Japan, and laiwan and occupationally exposed
cohorts from around the world were considered. It was concluded that available evidence did not
demonstrate serious adverse effects such as cancer, inexposed adult cohorts but did provide indica-
tions ofpossibleneurobehavioral effects inchildrenexposed in utero. Inaddition, workshop partici-
pants described newly developed markers of exposure and techniques for assessing endocrinologi-
cal, immunological, and neurological effects and suggested these be applied to epidemiological
studies ofthe effects of polyhalogenated compounds. Other recommendations included identifica-
tion of other cohorts and development of a large registry of exposed individuals; performance of
detailed studies of reproductive function and outcomes in exposed populations; and follow up of
neurobehavioral effects in offspring of exposed women.
Introduction
The focus ofthisworkshop was to determine the cur-
rentstatusofknowledge concerningthetoxicityofhal-
ogenated biphenyls and related compounds to hu-
mans; summarize ongoing or planned research aimed
at increasing ourknowledge aboutthe humantoxicity
of these chemicals; and make recommendations for
future research that can best provide the information
that is needed. To accomplish this goal, 78 scientists
representing many fields of study participated in a
workshop on the Human Health Impacts of Halogen-
ated Biphenyls and Related Compounds on November
8 and 9, 1989, in Ann Arbor, Michigan. The invited
participants listened to prepared talks, had extensive
discussions, and a selected groupmettogethertomake
consensus recommendations.
Introductory speakers addressed the current under-
standingofthe mechanisticbasisforthetoxicity ofthe
polyhalogenated biphenyls and related compounds
(PHBs) based on animal and in vitro studies and also
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provided an overview of current knowledge about the
human toxicity of these compounds. Subsequent ses-
sionsdealtwithenvironmentallyexposedpopulations;
occupationally exposed populations; pediatric popula-
tions; andbiological measurementsandmarkersofex-
posure. The final half-day was devoted to developing
the recommendations that are provided at the end of
this report.
The workshop was initiated by the Division ofCan-
cer Etiology, National Cancer Institute, and was sup-
portedjointly by the National Cancer Institute (NCI),
Agency for Toxic Substances and Disease Registry
(ATSDR), Environmental Protection Agency (EPA),
and National Institute of Occupational Safety and
Health (NIOSH). The program was developed and the
conference organized by Lawrence J. Fisher, Director,
Institute for Environmental Toxicology, Michigan
State University, and David Schottenfeld, Chairman,
Department ofEpidemiology, School ofPublic Health,
The University ofMichigan.
Session 1: Overview
Steven Safe (Texas A&M) discussed the large body of
evidence showing that a number ofchemical families,
including the polychlorinated dibenzodioxins (PCDDS),
polychlorinated dibenzofurans (PCDFs), polychlorinated
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biphenyls(PCBs), andpolybrominatedbiphenyls(PBBs),
all have similar toxic effects in animals and appear to
actviathesamereceptormechanism(1).Theconstella-
tionofbiologicaleffectsproducedbythesechemicals in
experimental animals includes induction ofdrug me-
tabolizing enzymes, weight loss, thymic atrophy, and
reproductive dysfunction. The proposed mechanism of
action is initiated by interaction ofthe chemical with
acytosolicreceptor(theAhreceptor),followedbymove-
ment ofthe toxicant-receptor complex to the nucleus,
interactionwithresponsive geneticelementsresulting
in altered gene expression, and ultimately the mani-
festions oftoxicity.
These chemicals are all inducers ofenzymes respon-
sible for metabolism of xenobiotics. Two specific en-
zyme activities, aryl hydrocarbon hydroxylase (AHH)
and ethoxyresorufin-O-deethylase (EROD), are often
used as markers of exposure to PHBs. Studies have
shownthereisacorrelationbetweenthe in vitropoten-
ciesofthesecompounds asinducersofAHHandEROD
activitiesandtheir invivotoxiceffects; e.g.,weightloss
(2,3). This has led to the suggestion that AHH and
EROD induction activities measured in vitro can be
used as surrogates fortoxicity ofthe chemicals in vivo.
Although many ofthe PHBs elicit a similar pattern
of responses, their relative potencies may vary over
manyordersofmagnitude, evenwithinthemembersof
the same family, e.g., different congeners of PCDDs.
The dioxin congener 2,3,7,8-tetrachlorodibenzo-p-di-
oxin (TCDD) is considered the most toxic ofthis class
ofchemicals and is used as the standard for compari-
son. In general, the coplanar PCB molecules that are
sterically most similar to TCDD exhibit the highest
toxicity in laboratory animals. The relative potencies
ofthecongenersvarysomewhatwiththeassay system;
however, the order ofpotency ofthe coplanar PCBs is
3,3'4,4'5-penta CB > 3,3'4,4'5,5'-hexa CB > 3,3'4,4'-
tetra CB (2).
Relative potencies in enzyme induction assays have
beenusedinconjunctionwithcongener-specific analy-
sestoprovide estimates ofthe total activityofenviron-
mentally relevant mixtures of PHBs. For example, a
mixture ofPCBs and PCDFs could be assigned a total
activity by multiplying the concentrations and rela-
tive potencies of all the congeners present and then
summing these values. An alternative approach is to
assess the biological activity of the mixture directly
using the enzyme induction assays. The total activity
assessedbyeithermethodhasbeenusedasasurrogate
for estimating the toxicity ofthe mixture under inves-
tigation andfor some mixtures the toxicities have also
been determined. However, the extrapolation from en-
zyme induction assays to toxicity in humans or ani-
mals remains to be validated.
Recent studies suggest that specific PHBs can act as
2,3,7,8-TCDD antagonists of some Ah receptor-medi-
ated responses in rodent and mammalian cells in cul-
ture (4). These antagonists, exemplifiedby 1,3,6,8-sub-
stituted PCDFs and the commercial PCB mixture,
Aroclor 1254,typicallyexhibitlowAhreceptoragonist
activity and moderate affinity for the Ah receptor. For
example, cotreatment ofC57BL/6 mice with subeffec-
tive doses ofAroclor 1254 and effective dose (ED) 80-
100 doses of2,3,7,8-TCDD resulted in partial antago-
nism of 2,3,7,8-TCDD-mediated AHH and EROD in-
duction, cleftpalate, and immunotoxicity. These inter-
actions generally require antagonist/agonist ratios of
> 1000 and are both species and response dependent.
Another important finding from nonhuman studies
is that the PCB congener distribution in environmen-
tal samples (e.g., food fish) is quite different from the
composition ofthe parent commercial mixtures, such
astheAroclors. It appearsthat selective enrichmentof
several congeners, including the more toxic coplanar
PCOs, occurs in some environmental samples. The ex-
planationfortheseobservationsisnotfullyknownand
more analytical work is necessary to validate these
conclusions.
These results obtained from experiments in animal
and in vitro systems, coupledwith limitedhigh resolu-
tion analytical data, emphasizethe importance ofcon-
gener-specific analyses ofPHBs in assessing their po-
tential adverse effects in humans. More research on
nonhuman models is needed to assess the toxicity of
the large number of PCB congeners not yet studied,
elucidate basic mechanisms ofaction and interaction,
and provide the data necessary to fully interpret re-
sults from studies of human cohorts (5).
Renate Kimbrough (U.S. EPA) discussed exposures
and risks in human populations. Although there have
been a large number ofpeople exposed to PHBs, quan-
titative estimatesofexposurehave notbeenwelldevel-
oped and relationships between exposure and adverse
health outcomes have been difficult to document (6).
There is a background exposure as evidenced by mea-
surements inthe early 1980s ofthe general U.S. popu-
lation showing PCB serum levels averaging 5 to 7
ng/mL and adipose levels averaging 0.9 to 9.4 mg/kg.
There is great interindividual variation, and extrapo-
latingfrom serum levels to totalbody burden requires
great care.
A number of populations have been identified and
classified accordingtotype ofexposure, e.g., heavyfish
eaters, those exposed through ambient air, those ex-
posed in utero, andvariousworkergroups. Above-back-
ground serum PCB levels have been measured in a
number of these populations, with workers showing
the highest levels-up to 3500 ng/mL in serum.
Serum PCB levels appear to increase with age, and
there is some evidence of a correlation with high cho-
lesterol levels and alcohol consumption (without clini-
cally significant liver dysfunction). In women, PCB
levelsdecreasewithincreasinglactation, asthechemi-
cal is concentrated and excreted in milk.
Studies ofvarious PHB-exposed populations to date
have not shown a clear increase in mortality or cancer
incidence. There is some evidence ofadverse reproduc-
tive outcomes although the effects appear to be small.
Since the validity ofepidemiological studies depends
strongly on good measures of exposure and establish-
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ing a dose response, better and more consistent mea-
suresofexposurewillbeneededbeforetherelationship
between PHBs and human toxicity can be fully under-
stood (7).
Discussion
In response to questions, it was emphasized that in-
teractionsamongPHBs are species specific, andthere-
sults from animal studies cannot be generalized tohu-
mans. There are a number of levels at which antago-
nism ofPHB effects by lower potency PHB congeners
can occur: e.g., binding to receptor, accumulation of
complexes in nucleus and posttranscriptionally. The
mechanism ofaction for these antagonistic effects has
notyetbeenelucidated. Arelatedissue isthedifficulty
of distinguishing between differential sensitivity
and antagonism when a mixture of PHBs is being
evaluated.
Another issue raised was possible differences in con-
gener distribution in tissues related to route of ex-
posure. Although this has notbeenthoroughly investi-
gated, current data suggest that route of exposure is
not an important variable in the disposition ofPHBs.
Session II: Human Environmental
Exposures
The presentation by Masanori Kuratsune (Naka-
mura Grakuen College, Japan) was devoted to studies
of an environmentally exposed cohort in Japan. This
population, known as the "Yusho" cohort, consists of
individuals who were exposed to rice oil contaminated
with PCBs, PCDFs, and related compounds over a 6 to
8 month period in 1968. Using the enzyme induction
assayandextrapolatingfromresults inlaboratory ani-
mals, it was calculated that about 75% ofthe toxicity
of the mixture in the rice oil was due to PCDFs and
most ofthe remainder to PCBs, with a very small con-
tribution from PCDDs (8).
Approximately 1800 people were exposed and have
been followed during the past 20 years (9). The initial
severechloracnehasdeclinedsignificantly,butsomeof
the exposed individuals still show evidence ofdermal
toxicity. A calculation ofthe time required for nearly
total elimination of PCDFs from the patients' bodies
was made on the basis ofresults from repeated analy-
sesofstool samplesfromthe same individuals. The cal-
culated value was about 58 years.
Mortality inthepopulation atthe endof1983 was no
different from the nonexposed population. However,
there were some excess liver andlungcancerdeaths in
males. The excess ofliver cancer deaths was suspected
to be due to PHB exposure, although the present evi-
dence isnotconclusive. Oneconfoundingfactorwasthe
higher liver cancer incidence in the provinces where
the exposure occurred, as compared to the country as
a whole. In addition, the data included some liver can-
cerdeathsoccurringrelatively soonafterexposure and
not likely to be a consequence ofPHB exposure. Last,
confirmatory autopsies were not performed in several
cases, casting doubt on the diagnoses for these cases.
Women exposed during the Yusho incident have not
shown excess cancer mortality (10).
Chen-Chin Hsu (National Cheng-Kung University,
Taiwan) discussed the Taiwan or "Yucheng" incident,
which occurred in 1978-1979, which also involved in-
gestion of contaminated rice oil and affected almost
2000 individuals. Incomparisontothe Yushoincident,
theexposureswerelowerinmostindividuals. However,
effects onthe offspringbornto exposedpregnant wom-
en were evident. The most striking was hyperpig-
mentation, and manyoffspringwere described as cola-
colored. In addition, neuroectodermal toxicity was
noted in fetuses of exposed mothers (11).
Investigators focused on detection ofpossible behav-
ioral effects caused by in utero exposure, and 118 chil-
dren, ranging from 1 to 8 years ofage, were studied in
detailin 1985.Theywerecomparedtononexposedchil-
dren and also to siblings who were exposed directly
ratherthantransplacentally. Theresultsofthesestudies
indicated lower overall intelligence scores, hyperactiv-
ity, and greater behavioral problems in the children
born to PHB-exposed mothers compared to children in
referent groups. These were subtle effects, and there
wasnoevidenceofmentalretardation. Theresultssug-
gest that in utero exposure may cause deleterious ef-
fects not observed when exposure occurs after birth
(11). Follow-up ofthese children indicates that the dif-
ferences from the control group are increasing with
time, suggestingthatthe early effects may reflect per-
manent changes.
Harold Humphrey (Michigan Department ofPublic
Health) discussed some Michigan populations that
represent some ofthe largest cohorts exposedto PHBs.
These includeabout4000Michiganfarmersexposedto
PBBs in Michigan during a contamination incident in
1973-1974,over200membersoffarmfamiliesexposed
to PCBs that were used to line their silos, and about
600 Lake Michigan shoreline residents who ate large
amounts offish contaminated with PCBs and a num-
ber of other chemicals including p,p'-dichlorophenyl
dichloroethylene (DDE),chlordane, andmirex. Dataon
all ofthese cohorts have been collected since the early
1970s, and members ofeach group continue to be fol-
lowedsothatpossible long-termeffects canbedetected
(12,13).
In addition to collecting interview and medical rec-
ord data from members ofthese cohorts, periodic mea-
surements ofserum and adipose PHB levels have been
made. These studies ofPHB-exposed populations have.
shown acorrelationofbloodandadipose PBB andPCB
levelswithexposure, butnoconvincingevidence oftox-
icity due to these exposures has been found (13). More
intensive study is needed to determine if subtle, ad-
verse effects have occurred in members ofeach cohort
or their offspring.
Walter Rogan (NIEHS) described some other PHB-
exposedpopulations, including 5000 people exposed to
dioxin at Quail Run, Missouri, from 1971 to 1983 (14),
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about 600 people exposed to a mixture of dichlorodi-
phenyl trichloroethane (DDT), DDE, and PCBs in
Triana, AL (15), and those exposed to PCBs and their
combustion products in Binghamton, New York (16).
The largest available cohort, consisting of about
20,000 individuals, is from Seveso, Italy (17). This pop-
ulation, includingahighlyexposedgroupofabout700,
wasexposedtodioxins asthe result ofanindustrial ac-
cident in 1976. Up to the present, the only adverse di-
oxin-related effectthathasbeenobserved as aresult of
the Seveso incident ischloracne. However, anumber of
measurementsusedinotherepidemiological studiesof
PHB exposurehave notbeenperformed onthispopula-
tion. Because ofthe size ofthis cohort, it represents a
good opportunity to test for effects that are suggested
by the results obtained in cther studies, but which
have not yet been examined.
Discussion
A number ofissues were raised with respect to inter-
pretingtheresults ofstudies ofthese environmentally
exposed populations. One central problem is how to
combine these cohorts in a scientifically valid manner
to obtain a large enough population to establish corre-
lations, with a high degree ofconfidence, between ex-
posure andadverseeffects. Relatedtothiscentral issue
are a number of questions that must be answered: (a)
How comparable are exposure measures (e.g., serum
levels) performed by different laboratories or at differ-
enttimes inthe past?(b)How comparable are methods
ofsurveillance and classification ofadverse health ef-
fects? (c) How comparable are the control groups? (d)
How applicable are results derived from one ethnic
group to other ethnic groups? (e) How can measures on
one type ofsample (blood) be converted to measures of
other types of samples (fat)? (f) Can groups be com-
bined if different mixtures of PHBs were involved in
the exposure?
Session Ill: Occupationally Exposed
Populations
A presentation by Laurie Piacitelli (NIOSH) de-
scribed a NIOSH registry ofindividuals occupational-
ly exposed to 2,3,7,8-TCDD or hexachlorodibenzodi-
oxins(18). Atotal of6583 workers, who were employed
at 14plantsbetween 1942 and 1983, areintheregistry.
At present, 1469 ofthese workers are deceased. Both a
retrospective cohort mortality and a medical and re-
productive outcome study are being performed using
this cohort.
Serum samples were collected from 281 workers in
two plants and 260 unexposed referents. Workers had
a significantly higher mean lipid-adjusted serum
2,3,7,8-TCDD level (252 parts per trillion [ppt]) than
the referent group (7.8 ppt), even though worker sam-
ples were collected 15 to 37 years after last exposure.
To estimate serum levels in workers at the time oflast
occupational 2,3,7,8-TCDD exposure, extrapolations
were performed assuming a 7-year 2,3,7,8-TCDD half-
life. The mean extrapolated level was 2658 ppt for one
plant and 866 pptforthe other, confirmingthatthe oc-
cupational population had substantial exposure. The
serum 2,3,7,8-TCDD levels significantly correlated
with years ofexposure (19). A matrix for estimation of
occupational exposure isbeing developedfrom histori-
caldataonindustrialprocesses, fluidandtissueanaly-
ses, and industrial hygiene practices. Analysis of the
mortality study is underway and will be completed in
fiscal year 1990.
A second large occupational registry, described by
Eric Johnson(NIEHS), is international in scope and is
a combined effort of NIEHS and the International
Agency for Research on Cancer (IARC) (20,21). The
populations that are part ofthis registry are from 12
countries andincludebothmanufacturinganduserco-
horts that were exposed to phenoxy herbicides, chloro-
phenols, and hexachlorophene. There are almost
20,000 individualsenrolledinthisregistry atthepres-
ent,with atotal ofabout 30,000 anticipated. Mortality
andcancerincidenceanalysesarebeingconductedand
are almost complete. This population should be avail-
able to investigators for the study ofother end points,
such as reproductive effects and serum dioxin levels,
sometime in the future.
The third presentation in this session, by John
Brown, Jr. (General Electric), described results from a
study ofworkerpopulationsfromtwoplantsthat man-
ufacture capacitors. The major exposures were to the
Aroclors(PCBs)thatwere part ofthe dielectricfluid in
the capacitors. The Aroclors contained significant
levels of coplanar PCBs. For example, Aroclor 1254
contained 38 ppm of 3,3'4,4'5-PCB. PCDFs were also
found as contaminants in capacitor fluid samples but
at very low levels. Because ofthe automated nature of
the process, only about 200 out ofa total of2500 work-
ers in thesve plants could be classified as highly ex-
posed. Resu.'ts from this study have not demonstrated
acute (i.e., chloracne) or chronic toxicity, although
therewassome evidenceofinductionofmicrosomal en-
zymes (22,23). Two additional results were that half-
life ofthe PCBs in exposed workers was slowing with
time and was 6 to 12 years at the time oflast measure-
ment andthat higherchlorinated congeners appeared
to be retained in the body preferentially and have ex-
tremely long half-lives (24-26).
Discussion
Questionswereraisedregardingthepossibility ofes-
tablishing a PCB occupational registry using a num-
ber ofdifferent cohorts. It wassuggestedthatthere are
over 750 workers who have shown blood serum PCB
levels above 10 ppb. This cohort could be increased in
size if workers from small plants were identified and
included. The creation ofa PBB-exposed worker regis-
try was also suggested. The half-life data obtained in
the capacitor worker study led to requests for studies
to clarify the time course of PHB tissue distribution
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and redistribution following exposure. As with the en-
vironmentally exposed populations, a number ofprob-
lemsneedtobe resolved before different cohorts canbe
combined to increase the power ofthe epidemiological
results.
It wasalsopointed outinthe discussionthat compar-
ison of occupationally and environmentally exposed
populations is complicated by the differences in con-
gener mixtures to which the two types ofpopulations
wereexposed.Theworkers wereexposedtocommercial
mixtures, while environmentally exposed populations
(e.g., fish eaters) were exposed to mixtures that had
quite different congener distributions than those pres-
ent in the commercial products. More study is needed
toestimatewhateffectthese exposuredifferenceshave
on the potential for toxic responses.
Session IV: Pediatric Populations
WalterRogan(NIEHS)startedthissessionwith a de-
scription of a study performed on the offspring of
mothers who were exposed to background levels of
PCBs. It was carried out in North Carolina and initial-
ly enrolled about 900 mothers exhibiting a range of
levels of PCBs in milk. Offspring born from 1978 to
1982 were studied for 5 years. Attempts were made to
correlate child development with degree of PCB ex-
posure. Both on the Brazelton scales as newborns and
on the Bayley scales as 1-year olds, children in the top
5% oftransplacental exposure, as determined by milk
levels, showed delay in maturation of motor abilities
(27,28). The magnitude ofthe effects ofprenatal expo-
sure were small; a 1-ppm increase in PCB milk level in
the mother was associated with a 1-point reduction in
the Bayley score ofcognitive function. There appeared
to be no relationship between measured development
and exposure through breast milk.
A secondpediatric study, described by Joseph Jacob-
sen (Wayne State University), was performed on the
offspringof242motherswhoregularlyconsumedLake
MichiganfishcontaminatedwithPCBsandother com-
pounds and71 motherswhodidnoteatthesefish. Mea-
surements were made ofboth physical and behavioral
characteristics ofchildren as well as cord serum, ma-
ternal serum, and breast milk PCBs levels (29). Re-
sults indicated decreased birth weight and head cir-
cumference as well as reduced gestational age in the
offspring of the most heavily exposed women when
comparedto women inthe same localewhodid not con-
sume fish (30). In addition, exposed infants exhibited
poorer central nervous system function at 7 months of
age, as indicated by poorer performance on a widely
used test ofinfant visual recognition memory (31). Re-
sults from this study also showed that transplacental
exposure was more effective in producing these effects
than postnatal exposure through breast milk (32,33).
Discussion
In response to questions, it was evident that differ-
encesintheanalyticalproceduresusedinthetwostud-
ies for determining PCBs make it difficult to make
comparisons between the two cohorts. In addition, it
wassuggestedthatenvironmental leadexposure inin-
fants might also contribute to abnormal central ner-
vous systemdevelopment in early childhood. However,
it was noted that there are some differences in the ef-
fectsobservedinthesestudiesandthoseobservedwith
lead. For example, lead affects mainly mental scores,
whilethepresentstudiesshowprimarilymotoreffects.
A related issue was whether careful studies ofheavy
metallevelsinthemothersorthefoodsupplyhadbeen
performed in the above studies ofPCB effects. Heavy
metal analyses had not been included, leaving open
the question ofa possible contribution ofexposures to
contaminants other than PCBs. In a different vein,
concern was expressed about possible impacts ofsam-
ple selectionandattrition ontheresultsofthe studyof
Michigan women.
Session V: Biological Measurements
and Markers of Exposure
Incontrasttoothersessionsintheworkshop, Session
V addressed techniques that might be useful for an-
swering a number ofoutstanding questions about the
human toxicity of the compounds of concern. George
Lucier(NIEHS)examinedthe issueofthecomparative
sensitivity ofhumans and animals to the effects ofthe
polyhalogenated biphenyls and related compounds. A
comparison was madebetweenPHB effects seen inrat
liversandthoseobservedinhumanplacentascollected
in connection with the Yucheng incident in Taiwan
(34). In humanplacentas, the PHBs showingthe high-
est affinity to the Ah receptor were the PCDFs. Al-
though enzyme induction was detected only inplacen-
tas from exposed individuals, induction in these tis-
sueswasnotcorrelatedwithPCDFconcentrations. Re-
sults from rat liver studies showed that the enzyme
induction response saturates at low concentrations,
while incidence ofcancer continues to increase above
these concentrations (35). Thus, the enzyme induction
does not appear to be a marker for carcinogenicity. Ef-
fects on receptor systems involved in cell proliferation
(e.g., epidermal growth factor [EGF], glucocorticoid,
and estrogen receptors) were generally similar in the
placenta and rat liver and dose-responses for these ef-
fects were similar to those for carcinogenic responses
(36,37). Quantitative and qualitative comparisons of
the rat and human data suggested that humans were
at least as sensitive as rats to several biochemical ef-
fects of PHBs (38). However, these conclusions are
basedon anumberofcriticalassumptions, andfurther
research is needed to establish relationships between
PHB exposure and functional changes.
George Lambert(LoyolaUniversity Stritch School of
Medicine) discussed human P-450I enzyme activity as
a biomarker and described the use ofcaffeine (labeled
withstableisotope)breathtesttomonitorP-450Iactiv-
ity in humans. He indicated that P-450I activity can
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predicttoxicpotential ofPHBs inanimalsbutthatthis
relationship has not been established in humans (39).
Studies of PBB-exposed individuals from Michigan
showed greater P-450I enzyme activity compared to
controls, as measured by the breath test. There was a
good correlation between the rate of caffeine metab-
olism; i.e., P-450I activity and PBB serum levels in
adults (40). However, exposed prepubescent children
did not show evidence of enzyme induction as mea-
sured by the breath test. Similar results were found
withthe Yuchengpopulations. The caffeine breathtest
promises to be a valuable technique for assessing ex-
posure and enzyme induction in adults but may not
be suitable for studying such effects in prepubescent
children.
Walter Piper (University ofMichigan) discussed pos-
sible PCB-related effects on the endocrine system that
mightbe measured inhumans. Abasis forthis work is
research showingthat steroid synthesis is P-450-medi-
ated and reports indicating that various hormone
levels are affected by TCDD exposure in laboratory
animals. Up to now, there has been insufficient study
ofthetimecourseoftheseresponses. Preliminary stud-
ies, such asthoseofadrenocorticotropichormone(ACTH)
response to TCDD exposure in the rat indicate a rapid
response, as early as one day after treatment. Other
work showed a TCDD-induced decrease in luteinizing
hormone lasting about 3 days and followed by a return
tonormal levels. Basedoncurrentdata, thehalf-lifefor
P-450-mediated reactions is from 1 to 5 days. More de-
tailed studies ofthe effects ofPHBs on endocrine sys-
tems in animals may provide valuable information
aboutthe mode ofactionofthesechemicals inhumans.
In addition, hormone levels and responses may be use-
ful as markers ofexposure to PHBs. Measurements of
such levels can be made in a number ofdifferent body
fluids including blood, urine, and saliva (41,42).
Roderick Nairn (University of Michigan) presented
the immunosuppressive effects produced by PHBs and
discussed their possible use as markers of exposure.
Early reports from studies ofPBB-exposed farmers in-
dicated some immunological effects, but the studies
used relatively crude measures of immune function
(43). More sensitive methods have become available,
such as using antigenic probes and cell-sorting analy-
sistoexamine subsetsoflymphocytes, and acareful re-
examination of exposed populations using this newer
methodology is now appropriate. In addition, immuno-
logical responses have the potential to be very im-
portant as biomarkers of exposure because they are
very sensitive, quite specific, and often persist for long
periods oftime. More work needs tobe done in develop-
ing applications of available immunological tech-
niques to the study ofPHB exposures.
Thelastspeaker, JosephArezzo(Albert EinsteinCol-
lege of Medicine), described new quantitative tech-
niques for assessing both peripheral and central ner-
vous systemfunction inhumans. There are avariety of
such tests that have become available, some of which
can be self-administered (44-47). For example, new
equipment is available to test distal sensory function.
Thiscanbe usedto assessperipheral neuropathies. Vi-
bration testing can assess large fiber function, and
thermaltestingcanbeusedforsmallfiberassessment.
Results from these and other recently developed tech-
niques can be combined to provide an accurate assess-
ment ofthepresence or absence ofneurological deficits
as well as diagnostic information about the type ofef-
fect and the possible site of action (48). Such studies
could be valuable in assessing PHB toxicity as well as
possibly indicating that exposure at toxicologically
significant levels has occurred.
Workshop Recommendations
1) Perform congener-specific analyses oftissues and
fluids obtainedfrom exposed andreferent populations.
Correlate exposure history with presence of specific
congeners and biomarkers ofexposure. Measure bind-
ing of specific congeners to Ah receptors in selected
human tissues.
Rationale: It is clear from laboratory studies that
older analytical methods measuring total levels of
PHBs; e.g., incompletely separated PCB mixtures, do
not provide sufficient information to make valid com-
parisons among exposed populations. Because the bio-
logical potency of individual congeners varies widely
and because some congeners may act as antagonists,
the potential toxicity ofany PHB mixture must be as-
sessed on a congener specific basis.
2)Makedetailedstudiesofreproductivefunctionand
outcomes in exposed and referent populations.
Rationale: Reproductive effects (decreased fecundity
and skeletal abnormalities) are seen consistently in
lower animals exposed to PHBs. Such effects are ob-
served in wildlife populations exposed to PHB mix-
tures similar to those involved in human exposures.
3) Examine the feasibility ofestablishing registries
large enoughtodetectrelatively rare events. To accom-
plish this, it is important to look for groups ofexposed
individuals that may notyet have been identified. It is
also important to establish means ofstandardizing ex-
posure and effect measures.
Rationale: Most of the individual cohorts are too
small to detect effects that occur at low incidence. It is
not clear whether combining various cohorts will be
feasible or appropriate, but any such combination will
require comparable measures ofexposures and effects.
4)Neurobehavioral effectspreviouslyobservedinthe
offspring ofexposed individuals should be followed up.
This follow-up should include congener-specific analy-
ses, careful studies ofpossible confounding variables,
and biochemical measurements. In addition, new
neurological measurement techniques should be ap-
plied to these populations.
Rationale: Several cohorts of transplacentally ex-
posed offspring of PHB-exposed parents have been
identified and studied. The results ofthe studies sug-
gest this exposure is linked to abnormal motor andbe-
havioral development. Thus, these cohorts are impor-
162HUMAN HEALTH IMPACTS OF HALOGENATED BIPHENYLS 163
tant resources and shouldbe examined more carefully
to gain maximum scientific benefit.
5) Perform careful heavy metal analyses ofexposed
and referent populations.
Rationale: A number ofbehavioral effects associated
with PHB exposure in children are similar to those
caused by heavy metals. It would, therefore, be useful
to investigate whether heavy metals, especially lead,
contribute to the effects observed with PHB exposure.
6)Newtechniquesofneurotoxicological, immunotox-
icological, endocrinological assessment should be ap-
plied to exposed and referent populations of both
adults andchildren. Results inhumans shouldbe com-
pared to those in other species.
Rationale: Newquantitativetechniquesforstudying
PHB effects in humans have become available. With
these techniques it ispossible todetermine ifthe same
effectsfound inanimals occur inhumans and, ifso, the
relative sensitivity ofhumans comparedtothese other
species.
7)Continue tomonitor cancerincidence andmortali-
ty in exposed populations using appropriate and con-
sistent diagnostic parameters.
Rationale: The latency period for appearance ofcan-
cers in humans due to PHB exposure is unknown and
maybe decades. Many ofthe more highly exposed pop-
ulations will be reaching the expected limit ofthis la-
tency period in the next 10 years, and intensive moni-
toring is needed to evaluate the possible link between
PHB exposure and cancer.
8) Explore the idea ofestablishing a PHB epidemio-
logical researchcenterorcenterstofacilitatethe study
of available cohorts.
Rationale: At present, studies of cohorts are per-
formedonanadhocbasiswith aminimumofcoordina-
tion. As a result, studies which could be done coopera-
tively are performed separately, often with a greater
cost and a loss of data. This problem could be mini-
mizedwiththe establishment ofsuch centers. Anaddi-
tional research priority that could be facilitated by
such a center is the standardization ofbiological and
chemical measurements performed on PHB-exposed
populations.
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